This inventor holds 2 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2000
Title: Keiji Hemmi: A Legacy of Innovation in Pharmaceutical Science
Introduction
Keiji Hemmi was a notable inventor in the field of pharmaceutical science, recognized for his contributions to the development of innovative compounds. He was based in Tsukuba, Japan, and his work has left a lasting impact on the industry. Hemmi held a total of 2 patents, showcasing his dedication to advancing medical science.
Latest Patents
Among his latest patents, Hemmi developed amino acid derivatives and their use as phospholipase A₂ inhibitors. He also worked on peptide compounds, their preparation, and various uses. These inventions reflect his commitment to exploring new therapeutic avenues.
Career Highlights
Throughout his career, Hemmi was associated with Fujisawa Pharmaceutical Company, Ltd., where he contributed significantly to research and development. His work at the company allowed him to collaborate with other talented scientists and push the boundaries of pharmaceutical innovation.
Collaborations
Hemmi collaborated with esteemed colleagues such as Hirokazu Tanaka and Naoki Fukami. Their combined efforts in research have led to advancements in the understanding and application of pharmaceutical compounds.
Conclusion
Keiji Hemmi's contributions to pharmaceutical science through his patents and collaborations have made a significant impact on the field. His legacy continues to inspire future generations of inventors and researchers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile